Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alen, M. |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A.H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y.A. |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P. |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J. |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S. |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T. |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Rämet, M(ika) |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ruskoaho, H. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Tjäderhane, L. |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Antibodies to malondialdehyde-acetaldehyde modified low-density lipoprotein in patients with newly diagnosed inflammatory joint disease. | Hörkko, S. | 29 days | save |  |  |  | |
| Carotid artery calcification in panoramic radiographs associates with oral infections and mortality. | Hörkko, S. | 57 days | save | | | | |
| Immunological and Microbiological Profiling of Cumulative Risk Score for Periodontitis. | Hörkko, S. | 80 days | save | | | | |
| Humoral immune response to heat shock protein 60 of Aggregatibacter actinomycetemcomitans and cross-reactivity with malondialdehyde acetaldehyde-modified LDL. | Hörkko, S. | 215 days | save | | | | |
| Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients. | Hörkko, S. | 266 days | save | | | | |
| Saliva and Serum Immune Responses in Apical Periodontitis. | Hörkko, S. | 489 days | save | | | | |
| Amyloid-Targeting PET Tracer [18F]Flutemetamol Accumulates in Atherosclerotic Plaques. | Hörkko, S. | 586 days | save | | | | |
| Salivary IgA to MAA-LDL and Oral Pathogens Are Linked to Coronary Disease. | Hörkko, S. | 643 days | save | | | | |
| Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein. | Hörkko, S. | 1019 days | save | | | | |
| IgA antibodies to phosphocholine associate with long-term cardiovascular disease risk. | Hörkko, S. | 1036 days | save | | | | |
| Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis. | Hörkko, S. | 1062 days | save | | | | |
| Extracellular lipids accumulate in human carotid arteries as distinct three-dimensional structures and have proinflammatory properties. | Hörkko, S. | 1072 days | save | | | | |
| Natural IgM antibodies in the immune defence against neoehrlichiosis. | Hörkko, S. | 1209 days | save | | | | |
| Natural Monoclonal Antibody to Oxidized Low-Density Lipoprotein and Aggregatibacter actinomycetemcomitans. | Hörkko, S. | 1214 days | save | | | | |
| Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans. | Hörkko, S. | 1250 days | save | | | | |
| Intestinal alkaline phosphatase at the crossroad of intestinal health and disease - a putative role in type 1 diabetes. | Hörkko, S. | 1296 days | save | | | | |
| A purified MAA-based ELISA is a useful tool for determining anti-MAA antibody titer with high sensitivity. | Hörkko, S. | 1344 days | save | | | | |
| Hypoxia-Inducible Factor-Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis. | Hörkko, S. | 1726 days | save | | | | |
| Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli. | Hörkko, S. | 1736 days | save | | | | |
| Characterization of a natural mouse monoclonal antibody recognizing epitopes shared by oxidized low-density lipoprotein and chaperonin 60 of Aggregatibacter actinomycetemcomitans. | Hörkko, S. | 1742 days | save | | | | |
| Association of periodontitis with persistent, pro-atherogenic antibody responses. | Hörkko, S. | 1872 days | save | | | | |
| Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. | Hörkko, S. | 2138 days | save | | | | |
| High-fat meals induce systemic cytokine release without evidence of endotoxemia-mediated cytokine production from circulating monocytes or myeloid dendritic cells. | Hörkko, S. | 2245 days | save | | | | |
| Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis. | Hörkko, S. | 2260 days | save | | | | |
| Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals. | Hörkko, S. | 2317 days | save | | | | |
| HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction. | Hörkko, S. | 2370 days | save | | | | |
| Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall. | Hörkko, S. | 2533 days | save | | | | |
| Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts. | Hörkko, S. | 2554 days | save | | | | |
| Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes. | Hörkko, S. | 2567 days | save | | | | |
| Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques. | Hörkko, S. | 2645 days | save | | | | |
| Enhanced polyamine catabolism disturbs hematopoietic lineage commitment and leads to a myeloproliferative disease in mice overexpressing spermidine/spermine N (1)-acetyltransferase. | Hörkko, S. | 2667 days | save | | | | |
| Modified lipoprotein-derived lipid particles accumulate in human stenotic aortic valves. | Hörkko, S. | 2693 days | save | | | | |
| Effects of a Single Bout of Interval Hypoxia on Cardio-Respiratory Control in Patients with Type 1 Diabetes Mellitus. | Hörkko, S. | 2702 days | save | | | | |
| The absence of macrophage Nrf2 promotes early atherogenesis. | Hörkko, S. | 2834 days | save | | | | |
| Carbamyl adducts on low-density lipoprotein induce IgG response in LDLR<sup>-/-</sup> mice and bind plasma autoantibodies in humans under enhanced carbamylation. | Hörkko, S. | 2843 days | save | | | | |
| Low plasma antibodies specific for phosphatidylethanol in alcohol abusers and patients with alcoholic pancreatitis. | Hörkko, S. | 2932 days | save | | | | |
| Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. | Hörkko, S. | 2988 days | save | | | | |
| Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a. | Hörkko, S. | 3264 days | save | | | | |
| High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism. | Hörkko, S. | 3806 days | save | | | | |
| Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice. | Hörkko, S. | 3906 days | save | | | | |
| | 
report | | | |
|
